Loading…
Fierce Drug Dev Forum 2019 has ended
avatar for Bola Akinlade, M.D.

Bola Akinlade, M.D.

REGENERON
Vice President, Head, General Medicine Therapeutic Area
Dr. Bola Akinlade is the Head and Vice President for Regeneron’s General Medicine Therapeutic Area. In his current role, he leads programs in pain, rheumatology, allergic disease and transplantation. Upon joining Regeneron in 2015, Dr. Akinlade led the immunology and inflammation clinical development team, playing a pivotal role in the approval of Dupixent® (dupilumab).

Dr. Akinlade is board-certified in Internal Medicine. He received his medical degree from the University of Ibadan and residency training in Internal Medicine at Lagos University Teaching Hospital, both in Nigeria, and finished residency at the University of Connecticut, serving as Chief Resident. He worked as an attending physician for 15 years. He joined Abbott Laboratories in 2003 and Astellas in 2008, where he led drug development teams in anti-infective, immunology, urology and nephrology. Dr. Akinlade is an American College of Physicians fellow and earned his M.B.A. from the Kellogg School of Management, Northwestern University.

My Speakers Sessions

Monday, October 28
 

3:15pm